AFSC Streamlining Services

Mar 17, 2021

Alberta's Agriculture Financial Services Corporation announcing some key changes this week.

AFSC will amalgamate five branches with neighbouring offices in an effort to streamline services.

The five one-employee offices affected are in High River, High Prairie, Rimbey, Smoky Lake and Spirit River, all impacted clients will be notified of the changes immediately and connected to a branch in close proximity to serve their needs.

CEO Darryl Kay says these are very difficult decisions.

"AFSC has an ongoing responsibility to evaluate its operations and determine how we can improve to deliver more value to our clients and all Albertans. We are thankful for the relationships we’ve had in those communities. These decisions will not interrupt the relationship-based service clients expect from AFSC."

AFSC also announcing two program changes, which will help support long term program sustainability.

The Spring Price Endorsement will be discontinued effective immediately, and the 20 per cent top up payment for the Wildlife Damage Compensation Program, will be eliminated.

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.